The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination
Open accessAbstract
BACKGROUND: Tumor-associated macrophages (TAMs) of the M2 phenotype are known to promote tumor proliferation and to be associated with a poor prognosis in numerous cancers. Here, we investigated whether M2 macrophages participate in the development of peritoneal dissemination in gastric cancer. METHODS: The characteristics of peritoneal macrophages in gastric cancer patients with or without peritoneal dissemination were examined by flow cytometry and the real-time quantitative polymerase chain reaction. The effects of M2 macrophages on phenotypic changes of the gastric cancer cell line MKN45 were assessed with a direct or indirect co-culture system in vitro and an in vivo mouse xenograft model. RESULTS: The number of peritoneal macrophages with the M2 phenotype (CD68(+)CD163(+) or CD68(+)CD204(+)) was significantly higher in gastric cancer patients with peritoneal dissemination than in those without peritoneal dissemination. Higher expression of the M2-related messenger RNAs (IL-10, vascular endothelial growth factor A, vascular endothelial growth factor C, matrix metalloproteinase 1, and amphiregulin) and lower expression of M1-related messenger RNAs (TNF-α, CD80, CD86, and IL-12p40) were also confirmed in the TAMs. Macrophage co-culture with gastric cancer cells converted M1 phenotype into M2 phenotype. Moreover, the coexistence of MKN45 cells with M2 macrophages resulted in cancer cell proliferation and an acceleration of tumor growth in the xenograft model. CONCLUSIONS: Intraperitoneal TAMs in gastric cancer patients with peritoneal dissemination were polarized to the M2 phenotype, and could contribute to tumor proliferation and progression. Therefore, intraperitoneal TAMs are expected to be a promising target in the treatment of peritoneal dissemination in gastric cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 1×
“However, this classification is a purely operational definition, because macrophages can adopt a large variety of phenotypes deviating from this classification, and may even acquire the properties of both M1 and M2 cells [23, 36, 37].”
BackgroundMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“Gene expression profiles of TAMs in various cancers have been reported [23, 24].”
BackgroundMacrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538 · cited 1×
“The tumor microenvironment consists of many different kinds of cells, including endothelial cells, fibroblasts, lymphocytes, and macrophages [8–11].”
BackgroundCoordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544 · cited 1×
“However, this classification is a purely operational definition, because macrophages can adopt a large variety of phenotypes deviating from this classification, and may even acquire the properties of both M1 and M2 cells [23, 36, 37].”
BackgroundGlobal cancer statistics in the year 2000
Parkin, D. M. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00486-7 · Cited by 2,445
(2011) · Hepatogastroenterology · doi:10.5754/hge11753 · Cited by 2,435
Distinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
Koizumi, W., Narahara, H., Hara, T., Takagane, A., Akiya, T., Takagi, M., Miyashita, K., Nishizaki, T., Kobayashi, O., Takiyama, W., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70035-4 · Cited by 1,847
Macrophages, innate immunity and cancer: balance, tolerance, and diversity
Mantovani, A., & Sica, A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.009 · Cited by 1,484
Sica, A., Schioppa, T., Mantovani, A., & Allavena, P. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.003 · Cited by 1,451
Hallmarks of cancer: Interactions with the tumor stroma
Pietras, K., & Östman, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.045 · Cited by 1,141
Discovery of Endothelial to Mesenchymal Transition as a Source for Carcinoma-Associated Fibroblasts
Zeisberg, E. M., Potenta, S., Xie, L., Zeisberg, M., & Kalluri, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3127 · Cited by 1,011
Possible involvement of the M2 anti‐inflammatory macrophage phenotype in growth of human gliomas
Komohara, Y., Ohnishi, K., Kuratsu, J., & Takeya, M. (2008) · The Journal of Pathology · doi:10.1002/path.2370 · Cited by 738
Jaguin, M., Houlbert, N., Fardel, O., & Lecureur, V. (2013) · Cellular Immunology · doi:10.1016/j.cellimm.2013.01.010 · Cited by 518
Role of macrophages in tumour progression
Siveen, K. S., & Kuttan, G. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.02.011 · Cited by 353
Loberg, R. D., Ying, C., Craig, M., Day, L. L., Sargent, E., Neeley, C., Wojno, K., Snyder, L. A., Yan, L., & Pienta, K. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1286 · Cited by 333
Stromal cells can contribute oncogenic signals
Tlsty, T. D. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0361 · Cited by 321
Kim, M. A., Lee, H. S., Lee, H. E., Jeon, Y. K., Yang, H. K., & Kim, W. H. (2008) · Histopathology · doi:10.1111/j.1365-2559.2008.03021.x · Cited by 283
Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma
Hasita, H., Komohara, Y., Okabe, H., Masuda, T., Ohnishi, K., Lei, X. F., Beppu, T., Baba, H., & Takeya, M. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01614.x · Cited by 275
Reinartz, S., Schumann, T., Finkernagel, F., Wortmann, A., Jansen, J. M., Meissner, W., Krause, M., Schwörer, A., Wagner, U., Müller‐Brüsselbach, S., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28335 · Cited by 271
Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma
Komohara, Y., Hasita, H., Ohnishi, K., Fujiwara, Y., Suzu, S., Eto, M., & Takeya, M. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01945.x · Cited by 264
Lieto, E., Ferraraccio, F., Orditura, M., Castellano, P., Mura, A. L., Pinto, M., Zamboli, A., De Vita, F., & Galizia, G. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9596-0 · Cited by 237
Galizia, G., Lieto, E., Orditura, M., Castellano, P., Mura, A. L., Imperatore, V., Pinto, M., Zamboli, A. G. I., Vita, F. D., & Ferraraccio, F. (2007) · World Journal of Surgery · doi:10.1007/s00268-007-9016-4 · Cited by 149
Tumor-associated macrophage (TAM) infiltration in gastric cancer.
Ishigami, S., Natsugoe, S., Tokuda, K., Nakajo, A., Okumura, H., Matsumoto, M., Miyazono, F., Hokita, S., & Aikou, T. (2003) · PubMed · Cited by 138
Galizia, G., Lieto, E., Ferraraccio, F., Vita, F. D., Castellano, P., Orditura, M., Imperatore, V., Mura, A. L., Manna, G. L., Pinto, M., et al. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.05.052 · Cited by 137
Niino, D., Komohara, Y., Murayama, T., Aoki, R., Kimura, Y., Hashikawa, K., Kiyasu, J., Takeuchi, M., Suefuji, N., Sugita, Y., et al. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02514.x · Cited by 133
Brown, C. L., Meise, K. S., Plowman, G. D., Coffey, R. J., & Dempsey, P. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.17258 · Cited by 130
Shirao, K., Boku, N., Yamada, Y., Yamaguchi, K., Doi, T., Goto, M., Nasu, J., Denda, T., Hamamoto, Y., Takashima, A., et al. (2013) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyt114 · Cited by 117
Wyler, L. G., Napoli, C., Ingold, B., Sulser, T., Heikenwälder, M. F., Schraml, P., & Moch, H. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.755 · Cited by 96
Yasumoto, K., Yamada, T., Kawashima, A., Wang, W., Li, Q., Donev, I. S., Tacheuchi, S., Mouri, H., Yamashita, K., Ohtsubo, K., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2475 · Cited by 55
Bone marrow derived “fibrocytes” contribute to tumor proliferation and fibrosis in gastric cancer
Terai, S., Fushida, S., Tsukada, T., Kinoshita, J., Oyama, K., Okamoto, K., Makino, I., Tajima, H., Ninomiya, I., Fujimura, T., et al. (2014) · Gastric Cancer · doi:10.1007/s10120-014-0380-0 · Cited by 54
Self-citationFushida, S., Oyama, K., Kinoshita, J., Yagi, Y., Okamoto, K., Tajima, H., Ninomiya, I., Fujimura, T., & Ohta, T. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s51916 · Cited by 46
Self-citationANZAI, H., Kitadai, Y., Bucana, C. D., Sanchez, R. R., Omoto, R., & Fidler, I. J. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10075-2 · Cited by 35
Hypermethylated Epidermal growth factor receptor (EGFR) promoter is associated with gastric cancer
Weng, X., Zhang, H., Ye, J., Kan, M., Liu, F., Wang, T., Deng, J., Tan, Y., He, L., & Liu, Y. (2015) · Scientific Reports · doi:10.1038/srep10154 · Cited by 26
Milky spot macrophages remodeled by gastric cancer cells promote peritoneal mesothelial cell injury
Liu, X., Miao, Z., Zhao, T., Wang, Z.-N., Xu, Y., Gao, J., Wu, J.-H., You, Y., Xu, H., & Xu, H.-M. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.08.073 · Cited by 25
Cited by
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Li, W., Zhang, X., Wu, F., Zhou, Y., Bao, Z., Li, H., Zheng, P., & Zhao, S. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2131-y · Cited by 359
Tumor microenvironment in gastric cancers
Oya, Y., Hayakawa, Y., & Koike, K. (2020) · Cancer Science · doi:10.1111/cas.14521 · Cited by 328
Emerging role of tumor cell plasticity in modifying therapeutic response
Qin, S., Jiang, J., Lu, Y., Nice, E. C., Huang, C., Zhang, J., & He, W. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00313-5 · Cited by 268
Yasuda, T., & Wang, Y. A. (2024) · Trends in Cancer · doi:10.1016/j.trecan.2024.03.008 · Cited by 261
Metadata
- Authors
- Yamaguchi, T., Fushida, S., Yamamoto, Y., Tsukada, T., Kinoshita, J., Oyama, K., Miyashita, T., Tajima, H., Ninomiya, I., Munesue, S., Harashima, A., Harada, S., Yamamoto, H., & Ohta, T.
- Venue
- Gastric Cancer
- Published
- 2015-11-30
- Volume
- 19
- Issue
- 4
- Pages
- 1052-1065
- ISSN
- 1436-3291 (ISSN-L)
- 1436-3305
- OpenAlex
- W2184554934
- Cited by
- 277
- References
- 38
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.